Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a randomized double-blind controlled exploratory clinical study to evaluate the efficacy and safety of FB1006 in the treatment of amyotrophic lateral sclerosis (ALS) patients.
Epistemonikos ID: 83fd4d4f15edb49513cfa61b45fae2a7bf862fb0
First added on: May 15, 2024